Mum's relief over 'brutally unfair' drug access
A Coventry mother is "massively relieved" after being told her daughter will now have access to a life-enhancing drug indefinitely.
Phoebe's six-year-old daughter Flory lives with CLN2 Batten disease, a rare and untreatable genetic disorder affecting about 40 children in the UK.
After months of uncertainty, health bosses this week revealed those already taking or soon to start treatment could continue to have it beyond the end of May.
But Phoebe believes it is also "brutally unfair" not all young people affected will benefit, and has vowed to keep fighting so everyone can access the drug.
CLN2 Batten disease causes a rapid decline in a child's ability to walk, talk and see, with an average life expectancy of about 10 years.
Drug Brineura is the only approved treatment that slows the condition's progress, but NHS access was due to end in May.
The National Institute for Health and Care Excellence (NICE) revealed on Thursday NHS England (NHSE) had come to a new agreement with its maker, BioMarin, regarding existing patients.
But it costs about £500,000 per child per year, and is not being recommended for future patients "due to its high price and the limited evidence of long-term effectiveness".
After she had receiving confirmation Flory's fortnightly treatment would continue, Phoebe said: "Families will see our children living longer with a better quality of life, while being completely hopeless."
She said getting the drug on the NHS had been "absolutely monumental" for Flory, and she believed her daughter was still walking, climbing and eating thanks to it.
"To know that she's going to have access to this indefinitely... is everything," she said.
"This treatment completely changes the trajectory of her life. Before, her entire life was uncertain."
But while it is a massive relief for her family, she is determined to keep advocating for others.
Phoebe urged decision makers to do the right thing, adding they were "halfway there".
"Every child should be able to access this treatment," she said.
"It is is life-changing. To offer it some and not others seems brutally unfair."
NICE said it would keep working with NHSE and BioMarin towards a long-term deal for all patients after a managed access agreement ended in December.
"We know this is not entirely the news people in the Batten Disease community were hoping for," said NICE director of medicines evaluation Helen Knight.
"However, this is not the end of the story. We will continue to work with all parties towards a solution."
The Batten Disease Family Association said it was pleased with the agreement, but would continue to push for Brineura to be accessible for all children.
Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and Instagram.
Child with rare disease will still get vital drug
Relief as treatment for rare condition is extended
Mothers rally and urge action over access to drug
National Institute for Health and Care Excellence
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Britain morphing into ‘National Health State', says think tank
Britain is turning into a 'National Health State', a think tank has said after the Chancellor gave the NHS a major funding boost in her spending review. The health service was the big winner of Wednesday's spending review, receiving an extra £29 billion per year for day-to-day spending and more cash for capital investment. Overnight, the Resolution Foundation said Rachel Reeves's announcements had followed a recent trend that saw increases for the NHS come at the expense of other public services. Ruth Curtice, chief executive of the Resolution Foundation, said: 'Health accounted for 90% of the extra public service spending, continuing a trend that is seeing the British state morph into a National Health State, with half of public service spending set to be on health by the end of the decade.' Defence was another of Wednesday's winners, Ms Curtice said, receiving a significant increase in capital spending while other departments saw an overall £3.6 billion real-terms cut in investment. The Institute for Fiscal Studies (IFS) made similar arguments about 'substantial' investment in the NHS and defence coming at the expense of other departments, although the think tank's director Paul Johnson warned the money may not be enough. He said: 'Aiming to get back to meeting the NHS 18-week target for hospital waiting times within this Parliament is enormously ambitious – an NHS funding settlement below the long-run average might not measure up. 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' Ms Curtice added that low and middle-income families had also done well out of the spending review 'after two rounds of painful tax rises and welfare cuts', with the poorest fifth of families benefiting from an average of £1,700 in extra spending on schools, hospitals and the police. She warned that, without economic growth, another round of tax rises was likely to come in the autumn as the Chancellor seeks to balance the books. She said: 'The extra money in this spending review has already been accounted for in the last forecast. 'But a weaker economic outlook and the unfunded changes to winter fuel payments mean the Chancellor will likely need to look again at tax rises in the autumn.' Speaking after delivering her spending review, Ms Reeves insisted she would not have to raise taxes to cover her spending review. She told GB News: 'Every penny of this is funded through the tax increases and the changes to the fiscal rules that we set out last autumn.' Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
UK consumers urged not to buy ‘unsafe' American sweets amid cancer concerns
UK consumers are being urged not to buy a brand of 'unsafe' sweets which could increase the risk of cancer, the Food Standards Agency (FSA) has said. Candies from the Jolly Rancher brand contain mineral oils, a food additive which can pose health risks if consumed regularly over a sustained period of time, the agency said. The chemical compounds in the products: mineral oil aromatic hydrocarbons (Moah); and mineral oil saturated hydrocarbons, (Mosh); are used in confectionary to prevent stickiness and create a glossy appearance, but do not comply with UK law. US producer, Hershey, which owns the brand, has been working with the FSA to remove all Jolly Rancher products from the UK market since 2024 – but some businesses in Britain continue to import their products, the agency added. The affected products include the Jolly Rancher Hard Candy, 'Misfits' Gummies, Hard Candy Fruity 2 in 1, and Berry Gummies, the FSA said. A food alert published by the FSA on Wednesday said: 'Consumption of the affected sweets is of toxicological concern, especially in younger age groups and where consumers eat a lot of the products or eat them regularly. 'Moah can cause damage to DNA and has the potential to increase the risk of cancer, particularly if consumed in high quantities over a prolonged period of time. Moah is a genotoxic carcinogen, therefore no exposure is without risk to human health.' Wednesday 11 June 2025. Food Alert "For Action": To Consumers who have purchased and Food Businesses who have purchased and sold Jolly Rancher products manufactured by The Hershey Company #FoodAlert — Food Standards Agency (@foodgov) June 11, 2025 It added: 'If you have bought any of the above products, do not eat them. 'Instead, dispose of them at home. If you are concerned, notify your Trading Standards department or environmental health department in the local authority you purchased it. 'For consumers, don't buy them, and if you've eaten these products, there should be no immediate cause for concern, as food safety risk is low, but don't eat any more.' The agency has also urged UK retailers and food businesses to cease all imports and sales of the candy brand, and asked enforcement authorities to ensure the products are removed from the shelves. The FSA said: 'Food businesses who import these products are advised to discontinue import and distribution of products. 'Food businesses selling these products in the UK are advised to immediately stop sales, undertake product withdrawals and where there have been retail sales, to undertake product recalls. 'The Hershey Company, who is the brand owner, has taken action to remove these products from the UK market. 'We are asking enforcement authorities to make immediate contact with businesses who may have been supplied with or received the affected products, and to take action to ensure that the non-compliant and potentially unsafe products are withdrawn from the market and where sold at retail, recalled. 'We are also asking the local authorities to inform the FSA of product recall and withdrawal actions.'
Yahoo
an hour ago
- Yahoo
Yeovil dental hygienist named finalist for Ms Great Britain 2025
A dental hygienist from Yeovil has been named a finalist for the 2025 Ms Great Britain competition. Rafina O'Brien is using her platform to advocate for oral health, support charitable causes, and highlight the Somerset community. Her 'When She Smiles' campaign centres on women's oral health, a frequently neglected issue. She raises awareness of how hormonal changes during puberty, pregnancy, and menopause can harm gum and bone health, potentially resulting in severe consequences like low birth weight and premature birth. Ms O'Brien aims to educate women about the importance of taking charge of their dental health through community discussions and online initiatives. She said: "I believe oral health is about much more than just teeth. "It's about confidence, wellbeing, dignity, and overall health — and everyone deserves access to that, no matter their background." She also works with Dentaid, a charity that operates mobile dental units and clinics for people experiencing homelessness. Ms O'Brien volunteers at these clinics, teaches oral hygiene practices to schools and community groups, and organises fundraising events, such as recently completing three ultra-marathons in three months. She also served as the first dental hygienist on the world tour of HMS Queen Elizabeth in 2021, as seen in the BBC documentary, The Warship: Tour of Duty.
